Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
The summary for the Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional): This Notice of Funding Opportunity (NOFO) invites applications for a U54 Specialized Center (henceforth: Consortium) to provide resources, expertise, and coordination to advance innovative, high-quality research on palliative care for those with serious illness across the lifespan. This research infrastructure will encompass Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD), cancer, and other serious illnesses and populations relevant to the partnering Institutes, Centers, and Offices (ICOs). NIH currently funds many palliative care research projects across the ICOs, and there is a need for a structure to leverage synergies, coordinate efforts, develop the scientific workforce, and address remaining gaps in the field. The goals of this initiative include generating new scientific knowledge, in part through supporting pilot and exploratory studies; fostering development of early- and mid-career palliative care investigators; serving as a national platform to provide research resources and facilitate high-quality palliative care research; engaging healthcare systems and community-based organizations as research partners and settings for palliative care research; and disseminating research findings, best practices, data, and other impactful resources to the palliative care research and clinical communities. An important focus of the Consortiums work will be on facilitating research to understand and address disparities in access, quality, and use of palliative care services for health disparities populations or in underserved areas.
Federal Grant Title: | Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Education, Health, Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AG-25-002 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.242, 93.361, 93.393, 93.853, 93.865, 93.866 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | July 2nd, 2024 |
Original Application Deadline: | July 2nd, 2024 |
Posted Date: | February 21st, 2024 |
Creation Date: | February 21st, 2024 |
Archive Date: | August 7th, 2024 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | February 21st, 2024 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-002.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-te...
- • Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Out...
- • Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinic...
- • Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinic...
- • Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
- • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
- • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
- More Grants from the National Institutes of Health
- • CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research ...
- • NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Cl...
- • Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Cl...
- • Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-te...
- • Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)